Company Filing History:
Years Active: 2000-2001
Title: Innovations by Melissa A Christensen
Introduction
Melissa A Christensen is an accomplished inventor based in Palatine, IL (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of glycated hemoglobin assays. With a total of 2 patents, her work has the potential to enhance diabetes management and improve patient outcomes.
Latest Patents
One of her latest patents focuses on the determination of % glycated hemoglobin. This glycated hemoglobin assay utilizes a simple procedure for the determination of standardized %GHb in whole blood samples, which is correlated to the Diabetes Control and Complications Trial (DCCT). The process begins with a lysed whole blood sample that is incubated with a solid phase coupled with boronic acid or a similar boronate compound through known covalent linkage chemistries. Following this, a labeled antibody to human hemoglobin is added, and the resulting signal is directly proportional to the %GHb in the sample. The advantages of this method include high precision and the ability to automate the assay, allowing for high throughput. This innovation also consolidates testing, eliminating the need for separate measurements of GHb and total hemoglobin (THb).
Career Highlights
Melissa A Christensen is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to focus on developing innovative solutions that address critical health challenges.
Collaborations
Some of her notable coworkers include Evelyn Mok Lee and David A Westerberg, who have collaborated with her on various projects within the company.
Conclusion
Melissa A Christensen's contributions to the field of medical diagnostics through her innovative patents demonstrate her commitment to improving healthcare solutions. Her work continues to pave the way for advancements in diabetes management and patient care.